| NCT06891703 | [18F]ACI-15916 PET in α-synucleinopathies | RECRUITING | EARLY_PHASE1 | 2025-03-20 | 2026-03 | 2026-03 |
| NCT06891716 | [18F]ACI-19626 PET in TDP-43 Proteinopathies | RECRUITING | EARLY_PHASE1 | 2025-01-21 | 2026-11 | 2026-11 |
| NCT06015841 | A Study to Evaluate the Effects of ACI-7104.056 Vaccination in Patients With Early Stages of Parkinson's Disease | RECRUITING | PHASE2 | 2023-07-24 | 2028-01 | 2028-01 |
| NCT05462106 | A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study) | RECRUITING | PHASE1, PHASE2 | 2022-06-21 | 2026-06 | 2026-06 |
| NCT04373616 | A Study of ACI-24 in Adults With Down Syndrome | WITHDRAWN | PHASE2 | 2021-10 | 2024-10 | 2024-04 |
| NCT04445831 | A Study to Evaluate the Safety, Tolerability and Immunogenicity of Tau Targeted Vaccines in Participants With Early Alzheimer's Disease | COMPLETED | PHASE1, PHASE2 | 2019-07-31 | 2023-09-05 | 2023-09-05 |
| NCT02738450 | Safety, Tolerability and Immunogenicity of ACI-24 Vaccine in Adults With Down Syndrome | COMPLETED | PHASE1 | 2016-03 | 2020-06 | 2020-06 |